VTYX Raju Mohan buys $525K worth of shares
Nov 26, 2024, 5:33 AM
-15.30%
What does VTYX do
Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company, develops small molecule therapeutics for autoimmune diseases with a pipeline including VTX002, VTX958, VTX2735, and VTX3232. The company went public on October 21, 2021, and employs 74 people.
Raju Mohan bought 261,752 shares of VTYX on 25 November at $2.01 per share, worth a total of $525K. They now own 2,175,028 VTYX shares, or a 14% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
